Los Angeles-based UCLA Health has tapped Amir Iravani, MD, as director of the theranostics program.
Dr. Iravani will also serve as vice chair of clinical research in the department of nuclear medicine and theranostics.
He will work with the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center to “advance the integration of theranostics into cancer care, expand clinical trials and research opportunities and develop new collaborations in precision health,” the release said.
Dr. Iravani previously served as theranostics clinical director at Seattle-based Fred Hutchinson Cancer Center.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
